Your browser doesn't support javascript.
loading
Holistic Approach in the Management of Nonalcoholic Fatty Liver Disease.
Shrestha, Ananta; Pradhananga, Shrijana.
Afiliación
  • Shrestha A; Alka Hospital, Kathmandu, Nepal.
  • Pradhananga S; Department of Medicine, Gurkha Welfare Trust, Kathmandu, Nepal.
Euroasian J Hepatogastroenterol ; 12(Suppl 1): S51-S58, 2022 Jul.
Article en En | MEDLINE | ID: mdl-36466101
Nonalcoholic fatty liver disease (NAFLD), in a few decades, is expected to be the commonest cause of end-stage liver disease and liver cancer surpassing all other etiologies. Urbanization and modern lifestyle have led to global epidemic of NAFLD with alarming prevalence rates across the globe. Its multisystemic involvement manifests as metabolic syndrome, diabetes, cardiovascular disease, end-stage liver disease, and hepatic and extrahepatic malignancies. The absence of promising therapy for halting disease progression in NAFLD is a challenge that is not only limited to liver disease but also other organs involved. It is unrealistic to expect any significant impact of pharmacotherapies in overall survival of NAFLD patients, given that the morbidity and mortality in these patients are contributed by conditions other than that of liver. Liver-centric approach in managing NAFLD will be futile unless the problem is dealt in a holistic manner. Lifestyle modifications have been repeatedly appraised in prevention and treatment of various diseases linked to metabolic syndrome including NAFLD. Despite being inexpensive and highly efficacious in prevention and treatment of different manifestations of NAFLD, lifestyle intervention often fails to gather sufficient interest among patients and physicians alike. This review intends to highlight pleiotropic nature of this disease, limitations of currently available pharmacotherapies and evidence that emphasizing lifestyle intervention is the only way to holistically deal in patients with NAFLD. How to cite this article: Shrestha A, Pradhananga S. Holistic Approach in the Management of Nonalcoholic Fatty Liver Disease. Euroasian J Hepato-Gastroenterol 2022;12(Suppl 1):S51-S58.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Euroasian J Hepatogastroenterol Año: 2022 Tipo del documento: Article País de afiliación: Nepal Pais de publicación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Euroasian J Hepatogastroenterol Año: 2022 Tipo del documento: Article País de afiliación: Nepal Pais de publicación: India